Literature DB >> 24382662

Crystal structure and tautomerism of capecitabine.

Maura Malińska1, Piotr Krzeczyński, Ewelina Czerniec-Michalik, Kinga Trzcińska, Piotr Cmoch, Andrzej Kutner, Krzysztof Woźniak.   

Abstract

The crystal and molecular structure of capecitabine, an anticancer pharmaceutical substance, was solved and refined using single-crystal X-ray diffraction. The compound was synthesized from a derivative of cytidine by a modified method. The crystal of capecitabine for X-ray study was grown by seedless crystallization from a single solvent. The low and room temperature single-crystal X-ray crystallographic study revealed that capecitabine exists in the solid state exclusively in one of the two possible prototropic tautomers. In the molecular structure of this tautomer, the hydrogen atom is attached to the N3 nitrogen atom of the pyrimidine ring (imine tautomer) and not to the N(4) nitrogen of the carbamate (carbamate tautomer), as has been widely reported up to the present. The imine tautomer was also found to be thermodynamically preferred in the ab initio calculations. This finding indicates that the reported structural formula of capecitabine, as well as its systematic chemical name, must be revised.
© 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  X-ray crystallography; ab initio calculations; capecitabine; stability; structure; tautomerism

Mesh:

Substances:

Year:  2013        PMID: 24382662     DOI: 10.1002/jps.23831

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Erratum: Capecitabine from X-ray powder synchrotron data. Corrigendum.

Authors:  Jan Rohlicek; Michal Husak; Ales Gavenda; Alexandr Jegorov; Bohumil Kratochvil; Andy Fitch
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-05-27

2.  Multinuclear NMR Measurements and DFT Calculations for Capecitabine Tautomeric Form Assignment in a Solution.

Authors:  Piotr Cmoch; Piotr Krzeczyński; Andrzej Leś
Journal:  Molecules       Date:  2018-01-13       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.